BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31135488)

  • 1. Autoimmune Pancreatitis Type 2: Diagnostic Utility of PD-L1 Immunohistochemistry.
    Gupta R; Neyaz A; Chougule A; Akita M; Zen Y; Forcione D; Castillo CF; Ferrone CR; Deshpande V
    Am J Surg Pathol; 2019 Jul; 43(7):898-906. PubMed ID: 31135488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and limitations of the histological diagnosis of type 1 autoimmune pancreatitis with endoscopic ultrasound-guided fine needle biopsy with large tissue amounts.
    Notohara K; Kamisawa T; Kanno A; Naitoh I; Iwasaki E; Shimizu K; Kuraishi Y; Motoya M; Kodama Y; Kasashima S; Nishino T; Kubota K; Sakagami J; Ikeura T; Kawa S; Okazaki K
    Pancreatology; 2020 Jul; 20(5):834-843. PubMed ID: 32624418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
    Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
    Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of histological features resembling autoimmune pancreatitis in neoplastic pancreas resections.
    Chen L; Orr CE; Wang T
    Histopathology; 2020 Oct; 77(4):673-677. PubMed ID: 32608526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.
    Xiang P; Zhang X; Wang C; Lang Y; Xu L; Huang L; Shen J; Feng ST
    BMC Cancer; 2019 Aug; 19(1):814. PubMed ID: 31419961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for diagnosing autoimmune pancreatitis with biopsy tissues.
    Notohara K; Kamisawa T; Fukushima N; Furukawa T; Tajiri T; Yamaguchi H; Aishima S; Fukumura Y; Hirabayashi K; Iwasaki E; Kanno A; Kasashima S; Kawashima A; Kojima M; Kubota K; Kuraishi Y; Mitsuhashi T; Naito Y; Naitoh I; Nakase H; Nishino T; Ohike N; Sakagami J; Shimizu K; Shiokawa M; Uehara T; Ikeura T; Kawa S; Okazaki K
    Pathol Int; 2020 Oct; 70(10):699-711. PubMed ID: 32767550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasound-guided fine needle biopsy specimens: an interobserver agreement study.
    Notohara K; Kamisawa T; Furukawa T; Fukushima N; Uehara T; Kasashima S; Iwasaki E; Kanno A; Kawashima A; Kubota K; Kuraishi Y; Motoya M; Naitoh I; Nishino T; Sakagami J; Shimizu K; Tomono T; Aishima S; Fukumura Y; Hirabayashi K; Kojima M; Mitsuhashi T; Naito Y; Ohike N; Tajiri T; Yamaguchi H; Fujiwara H; Ibuki E; Kobayashi S; Miyaoka M; Nagase M; Nakashima J; Nakayama M; Oda S; Taniyama D; Tsuyama S; Watanabe S; Ikeura T; Kawa S; Okazaki K
    Virchows Arch; 2022 Mar; 480(3):565-575. PubMed ID: 34820715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
    Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
    Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
    Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
    Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis.
    Zen Y
    Semin Diagn Pathol; 2024 Mar; 41(2):79-87. PubMed ID: 38184420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostaining With Immunoglobulin G Subclass Antibody Cocktail for Diagnosis of Type 1 Autoimmune Pancreatitis.
    Nakata R; Uehara T; Iwaya M; Asaka S; Kobayashi S; Sugano M; Higuchi K; Kusama Y; Nakazawa K; Nakaguro M; Kobayashi M; Tateishi A; Makino M; Kawaguchi K; Maejima T; Ishii K; Sano K; Shimojo H; Hori A; Otsuki T; Hamano H; Kawa S; Ota H
    Int J Surg Pathol; 2020 Dec; 28(8):844-849. PubMed ID: 32456567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
    Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
    Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.
    Ghassem-Zadeh S; Hufnagel K; Bauer A; Frossard JL; Yoshida M; Kutsumi H; Acha-Orbea H; Neulinger-Muñoz M; Vey J; Eckert C; Strobel O; Hoheisel JD; Felix K
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of efficient on-bead protein elution process coupled to ultra-high performance liquid chromatography-tandem mass spectrometry to determine immunoglobulin G subclass and glycosylation for discovery of bio-signatures in pancreatic disease.
    Shiao JY; Chang YT; Chang MC; Chen MX; Liu LW; Wang XY; Tsai YJ; Kuo TC; Tsai IL
    J Chromatogr A; 2020 Jun; 1621():461039. PubMed ID: 32295703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.